<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>

<!-- This file generated using Python HTMLgen module. -->
<HEAD>
  <META NAME="GENERATOR" CONTENT="HTMLgen 2.2.2">
        <TITLE>Drug Interaction Knowledge Base 1.2</TITLE>

 <LINK rel=stylesheet href="html/HTMLgen.css" type="text/css" title="html/HTMLgen.css">
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000" LINK="#0000FF" VLINK="#EE0000">
<span style="width: 60px"></span> 
<IMG src="./images/blank.gif" height="22" width="66" alt="blank.gif"> 
<IMG src="./images/blank.gif" height="22" width="66" alt="blank.gif"> 
<IMG src="./images/blank.gif" height="22" width="66" alt="blank.gif"> 
<H3>Drug Interaction Knowledge Base 1.2</H3>
<H2>diltiazem_inhibition_constant_cyp3a4</H2>
<HR>

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>

<!-- This file generated using Python HTMLgen module. -->
<HEAD>
  <META NAME="GENERATOR" CONTENT="HTMLgen 2.2.2">
        <TITLE></TITLE>

 <LINK rel=stylesheet href="html/HTMLgen.css" type="text/css" title="html/HTMLgen.css">
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000" LINK="#0000FF" VLINK="#EE0000">
<b>You can go to DIKB assertion index here:</b>  
<A HREF="/dikb-evidence/index.html">DIKB assertion index</A>
<br><b>You can go to DIKB the home page here:</b>  
<A HREF="/dikb-evidence/front-page.html">DIKB Front Page</A>

<P>

<a name="
diltiazem_inhibition_constant_cyp3a4
"></a>
<b>Assertion:
diltiazem inhibition_constant cyp3a4
</b>
<BR>
<A NAME="Evidence"></A>
<P><TABLE border=2 cellpadding=4 cellspacing=1 width="100%">
<CAPTION align=top><STRONG>Evidence</STRONG></CAPTION>
<TR><TD Align=left ><STRONG>Evidence For (item 0)</STRONG></TD>
<TD Align=left ><STRONG>Evidence Type: </STRONG>EV_EX_Met_Enz_Inhibit_Cyp450_Hum_Microsome</TD>
<TD Align=left ><STRONG>Pointer: </STRONG><a target="new" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15743977&query_hl=1">15743977</a></TD>
<TD Align=left ><STRONG>Reviewer: </STRONG>boycer</TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>Quote: </STRONG>Enzyme system: human liver microsomes<br><br>NADPH added: yes<br><br>substrate used: midazolam<br><br>reaction: midazolam-->1'-hydroxy-midazolam<br><br>Quote:<br>estimated k_i from Table 2: .48 microM/L</TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>Assumptions: </STRONG>midazolam_in_vitro_probe_substrate_of_enzyme_cyp3a4</TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>inhibition_constant: </STRONG>0.00022</TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>enzyme_system: </STRONG>Human_Liver_Microsomes</TD>
</TR>
<TR><TD Align=left ><STRONG>Evidence For (item 1)</STRONG></TD>
<TD Align=left ><STRONG>Evidence Type: </STRONG>EV_EX_Met_Enz_Inhibit_Cyp450_Hum_Microsome</TD>
<TD Align=left ><STRONG>Pointer: </STRONG><a target="new" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11422004&query_hl=1">11422004</a></TD>
<TD Align=left ><STRONG>Reviewer: </STRONG>boycer</TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>Quote: </STRONG><br>Enzyme system: human liver microsomes<br><br>NADPH added: yes<br><br>substrate used: testosterone<br><br>reaction: testosterone--&gt;6beta-OH-testosterone<br><br>Quote:<br>Verapamil and diltiazem inhibited testosterone 6beta-hydroxylation in a time- and concentration-dependent manner, key features of mechanism-based inactivation. Values for the inactivation parameters kinact and KI were 0.15 +/- 0.04 min-1 (mean +/- s.d.) and 2.9 +/- 0.6 microM, respectively, for verapamil and 0.07 +/- 0.01 min-1 and 3.3 +/- 1.5 microM, respectively, for diltiazem.</TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>Assumptions: </STRONG>testosterone_in_vitro_probe_substrate_of_enzyme_cyp3a4</TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>inhibition_constant: </STRONG>0.001</TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>enzyme_system: </STRONG>Human_Liver_Microsomes</TD>
</TR>
<TR><TD Align=left ><STRONG>Evidence For (item 2)</STRONG></TD>
<TD Align=left ><STRONG>Evidence Type: </STRONG>EV_EX_Met_Enz_Inhibit_Cyp450_Hum_Microsome</TD>
<TD Align=left ><STRONG>Pointer: </STRONG><a target="new" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10640508&query_hl=1">10640508</a></TD>
<TD Align=left ><STRONG>Reviewer: </STRONG>boycer</TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>Quote: </STRONG><br>Enzyme system: human liver microsome and recombinant human enzymes in insect cells<br><br>NADPH added: yes<br><br>substrate used: testosterone<br>reaction: testosterone--&gt;6beta-OH-testosterone<br><br>This study showed significant inhibition of 6beta-OH-testosterone in enzyme systems incubated with diltiazem. IC50 = 5.0microM, Ki = .5microM </TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>Assumptions: </STRONG>testosterone_in_vitro_probe_substrate_of_enzyme_cyp3a4</TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>inhibition_constant: </STRONG>0.0002255</TD>
</TR>
<TR><TD Align=left ></TD>
<TD Align=left ><STRONG>enzyme_system: </STRONG>Human_Liver_Microsomes</TD>
</TR>
</TABLE><P>

<BR>

</BODY> </HTML>

<b>You can go to DIKB assertion index here:</b>  
<A HREF="/dikb-evidence/index.html">DIKB assertion index</A>
<br><b>You can go to DIKB the home page here:</b>  
<A HREF="/dikb-evidence/front-page.html">DIKB Front Page</A>

<P>

<BR><BR><a rel="license" href="http://creativecommons.org/licenses/by-nc-sa/3.0/"><img alt="Creative Commons License" style="border-width:0" src="http://i.creativecommons.org/l/by-nc-sa/3.0/88x31.png" /></a><br /><span xmlns:dct="http://purl.org/dc/terms/" href="http://purl.org/dc/dcmitype/Dataset" property="dct:title" rel="dct:type">Drug Interaction Knowledge Base (DIKB)</span> by <a xmlns:cc="http://creativecommons.org/ns#" href="http://www.dbmi.pitt.edu/person/richard-boyce-phd" property="cc:attributionName" rel="cc:attributionURL">Richard D. Boyce</a> is licensed under a <a rel="license" href="http://creativecommons.org/licenses/by-nc-sa/3.0/">Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License</a>.

<P><HR>
<span style="width: 60px"></span> 
<IMG src="./images/blank.gif" height="22" width="66" alt="blank.gif"> 
<IMG src="./images/blank.gif" height="22" width="66" alt="blank.gif"> 
<IMG src="./images/blank.gif" height="22" width="66" alt="blank.gif"> 
<BR><IMG src="./images/logo.jpg" alt="logo.jpg" align="bottom">
<FONT SIZE="-1"><P>Copyright &#169 (c) 2005-2012 Richard David Boyce<BR>All Rights Reserved<BR>

Comments to author: <A HREF="mailto:&#114;d&#98;2&#48; &#97;t&#32;p&#105;t&#116; &#60;d&#111;t&#62; &#101;d&#117;">rdb20 at pitt <dot> edu</A><br>
Generated: Thu Dec 13, 2012 <BR><hr>
</FONT>
</BODY> </HTML>
